Literature DB >> 16112357

Primary cutaneous B-cell lymphoma.

Melissa A Bogle1, Christy C Riddle, Emily M Triana, Dan Jones, Madeleine Duvic.   

Abstract

Primary cutaneous B-cell lymphomas include extranodal marginal zone B-cell lymphoma, follicular lymphoma, large B-cell lymphoma, and, rarely, mantle cell lymphoma. Our purpose in conducting this review was to determine the clinical and behavioral characteristics of primary cutaneous B-cell lymphomas, their relationship to infectious triggers, and therapeutic response. We conducted a retrospective chart review of 23 adult patients presenting to the dermatology clinic at M. D. Anderson Cancer Center with primary cutaneous B-cell lymphoma between January 1999 and May 2003. Primary cutaneous B-cell lymphomas generally present on the head and neck, with the trunk and extremities afflicted to a lesser extent. Patients were found to have serologic evidence of prior infection with Borrelia burgdorferi (n = 10), Helicobacter pylori (n = 5), and Epstein-Barr virus (n = 6). Overall, treatment of primary cutaneous B-cell lymphoma should involve multiple modalities; however, specific treatment aimed at concurrent or suspected infection, particularly B burgdorferi, is a helpful adjunct and may achieve complete remission in a small subset of patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16112357     DOI: 10.1016/j.jaad.2005.04.043

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  8 in total

1.  Cutaneous lymphoma misdiagnosed as chronic lymphadenitis.

Authors:  Mircea Munteanu; Georgiana S Mohor; Flavia Baderca; Caius Solovan
Journal:  Int Wound J       Date:  2015-04-22       Impact factor: 3.315

Review 2.  Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.

Authors:  Meenal Kheterpal; Neha Mehta-Shah; Pooja Virmani; Patricia L Myskowski; Alison Moskowitz; Steven M Horwitz
Journal:  Curr Hematol Malig Rep       Date:  2016-06       Impact factor: 3.952

Review 3.  Investigating potential exogenous tumor initiating and promoting factors for Cutaneous T-Cell Lymphomas (CTCL), a rare skin malignancy.

Authors:  Ivan V Litvinov; Anna Shtreis; Kenneth Kobayashi; Steven Glassman; Matthew Tsang; Anders Woetmann; Denis Sasseville; Niels Ødum; Madeleine Duvic
Journal:  Oncoimmunology       Date:  2016-06-06       Impact factor: 8.110

4.  Polymerase chain reaction-based clonality analysis of cutaneous B-cell lymphoproliferative processes.

Authors:  Claudia Z Melotti; Maria Fernanda Carriel Amary; Miriam Nacagami Sotto; Timothy Diss; Jose Antonio Sanches
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

5.  Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases.

Authors:  Porcia T Bradford; Susan S Devesa; William F Anderson; Jorge R Toro
Journal:  Blood       Date:  2009-03-11       Impact factor: 22.113

6.  Borrelia infection and risk of non-Hodgkin lymphoma.

Authors:  Claudia Schöllkopf; Mads Melbye; Lars Munksgaard; Karin Ekström Smedby; Klaus Rostgaard; Bengt Glimelius; Ellen T Chang; Göran Roos; Mads Hansen; Hans-Olov Adami; Henrik Hjalgrim
Journal:  Blood       Date:  2008-04-18       Impact factor: 22.113

7.  Long-term Therapeutic Success of Intravenous Rituximab in 26 Patients with Indolent Primary Cutaneous B-cell Lymphoma.

Authors:  Stefanie Porkert; Pamela Mai; Constanze Jonak; Felix Weihsengruber; Klemens Rappersberger; Wolfgang Bauer; Ingrid Simonitsch-Klupp; Markus Raderer; Julia Valencak
Journal:  Acta Derm Venereol       Date:  2021-02-02       Impact factor: 3.875

Review 8.  The Multifaceted Role and Utility of MicroRNAs in Indolent B-Cell Non-Hodgkin Lymphomas.

Authors:  Pinelopi I Artemaki; Petros A Letsos; Ioanna C Zoupa; Katerina Katsaraki; Paraskevi Karousi; Sotirios G Papageorgiou; Vasiliki Pappa; Andreas Scorilas; Christos K Kontos
Journal:  Biomedicines       Date:  2021-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.